Institutional members access full text with Ovid®

Share this article on:

The Deadly Impact of Extreme Drug Resistance in Acinetobacter baumannii*

Spellberg, Brad MD; Bonomo, Robert A. MD

doi: 10.1097/CCM.0000000000000181
Editorials

Division of General Internal Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA; and, Division of General Internal Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA

Department of Medicine, Department of Pharmacology; and, Department of Molecular Biology and Microbiology, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Case Western Reserve University, Cleveland, OH

* See also p. 1081.

Dr. Spellberg received support for article research from the National Institutes of Health (NIH). His institution consulted for GlaxoSmithKlein, Adenium, Cardeas, Meiji, and aRigen. Dr. Bonomo received support for article research from the NIH.

© 2014 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins